The Mid-Term Clinical Follow-Up Using Drug-Eluting Balloons on Tibial Artery "De Novo" Lesions in Patients With Critical Limb Ischemia: A Cohort Study

Conclusions:
Our experience in addition to the existing literature supports the use of DEB in patients with CLI Rutherford class >3.

Source: Vascular and Endovascular Surgery - June 9, 2016 Category: Surgery Authors: Tolva, V., Casana, R., Huibers, A., Parati, G., Bianchi, P., Cireni, L., Ferrero, E., Halliday, A. Tags: Original Manuscripts Source Type: research